Search the Newsroom
Filter By
Showing 2771 - 2778 of 2778 results
Children’s Hospital of Philadelphia Named a 2024 Leading Disability Employer by the National Organization on Disability
Children’s Hospital of Philadelphia (CHOP) is honored to announce that it has received a Leading Disability Employer Seal for 2024 from the National Organization on Disability (NOD).
CHOP, Penn Researchers Show Strong Connection Between Handheld Cellphone Use and Risky Behavior Among Teen Drivers
Cell phone use was recorded in more than one-third of trips taken by teens in the study sample
Children’s Hospital of Philadelphia Researchers Discover Underlying Mechanisms that Make CRISPR an Effective Gene Editing Tool
Using state-of-the-art technology, researchers say understanding underlying movements and mechanisms may pave the way for more effective forms of CRISPR-based therapy.
Children’s Hospital of Philadelphia Researchers Find Hemophilia A Drug May Be Effective for Select People with Hemophilia B
Researchers at Children’s Hospital of Philadelphia (CHOP) found that emicizumab, a widely used drug for hemophilia A, could also improve blood clotting for select people with hemophilia B depending on their genes. The preclinical study, recently published in Blood, offers proof that this class of hemophilia A drug could potentially be used to treat hemophilia B.
Children’s Hospital of Philadelphia’s 22nd Annual Parkway Run & Walk presented by Citadel Credit Union Raises More than $1.95 Million to Bolster Pediatric Cancer Research and Care
On a September Sunday on the Ben Franklin Parkway, nearly 8,000 supports – comprising of more than 275 teams – participated in CHOP Cancer Center’s largest fundraiser, the Parkway Run & Walk, presented by Citadel Credit Union.
Children’s Hospital of Philadelphia’s Center for Data Driven Discovery in Biomedicine Receives Up to $10 Million ARPA-H Award to Create Tool for Sharing Data on Cancer and Rare Diseases
This award will help research, validate and implement a new model for sharing and integrating data at a national level.
CHOP Named 2024 Leading Disability Employer by the National Organization on Disability
We are honored to announce that CHOP has been given the NOD Leading Disability Employer Seal for 2024 by the National Organization on Disability (NOD) for the fourth time.
$14M NIH grant funds gene-editing research for rare metabolic diseases at Penn and CHOP
Researchers aim to develop personalized therapies for urea cycle disorders and other genetic conditions using advanced CRISPR technology.